Peptides 101: What They Are, Recent FDA Votes & Popular Chronic Illness Peptides ft. Max Swiergol

This week on Calling in Sick, Max Swiergol is back for a deep dive on one of the most viral and most misunderstood topics in the chronic illness and wellness space right now… PEPTIDES!!! You've seen them all over TikTok. You've probably heard of BPC-157. And you have almost certainly seen someone claim a peptide changed their life. But the clinical research is almost nonexistent… and that gap between popularity and evidence is exactly where this community is most vulnerable. We're diving into: 🧬 What peptides actually ARE — strings of 4 to 50 amino acids that can alter gene expression, regenerate tissue, decrease visceral fat, and increase growth hormone. The science is genuinely fascinating. 📋 The FDA regulatory peptide update — the Pharmacy Compounding Advisory Committee just voted to recategorize peptides to compoundable status (BPC-157, TB-500, KPV, Matrixtide, Semax, Epitalon, DSIP) 💉 Is BPC-157 the future for chronic illness? — what it is, how it works, why it's so prominent in the chronic illness space, and what the honest assessment of the evidence actually looks like 🔬 The ENDO-205 Clinical Trial Update — what it is, what Phase 1 clinical trial status means, and should you be excited The bottom line from this conversation: peptides are genuinely promising. The research is genuinely lacking. And this community deserves to know the difference. xx, Alex 💬 Comment: Have you ever tried a peptide, and what was your experience? TIMESTAMPS: Intro: 00:00:00 Welcome back to Calling in Sick! The Viral Rise of Peptides 00:00:16 What are peptides and why are they viral? 00:04:44 Navigating the peptide market as a chronic illness patient FDA Regulatory Discussions and Prominent Peptides: 00:08:21 Why the government is talking about recategorizing peptides 00:09:20 The Pharmacy Compounding Advisory Committee vote outcomes 00:11:14 A deep dive on BPC-157 in the chronic illness space 00:14:08 Dr. Abud Bakri and peptide transparency (ne1.study) 00:17:07 Endo 205 and endometriosis research 00:20:08 AI drug discovery and peptide predictors 00:24:00 New research around testing for Endometriosis Conclusion: 00:28:03 Where to find Max Dose online 00:29:18 Thank you for listening! ---------------------------------------------------------------- Stay connected and follow us on socials for more! • Instagram - https://www.instagram.com/callinginsickpod/ • TikTok - https://www.tiktok.com/@callinginsickpod • Facebook - https://www.facebook.com/profile.php?id=61558234607568 Connect with our guest, Max Swiergol! • Instagram - https://www.instagram.com/themaxdose/ • TikTok - https://www.tiktok.com/@themaxdose • YouTube - https://www.youtube.com/@Themaxdoseyt • Sign up for his newsletter - https://tr.ee/TdjGmsOp4V ---------------------------------------------------------------- Powered by: Just Media House -- https://www.justmediahouse.com/ Produced by: Alexandra Wildeson — https://www.instagram.com/alexandrawildeson/ Relevant Episode Links: • Dr. Abud Bakri - https://www.instagram.com/p/DZDYBIShrjW/ • Peptide Research Transparency - https://ne1.study/ • ENDO-205 - https://seed.nih.gov/portfolio/nih-portfolio-company-showcase/endocyclic-therapeutics #Peptides #BPC157 #Endo205 #FDAPeptides #ChronicIllness #PeptideTherapy #Endometriosis #ChronicIllnessTreatment #SpoonieLife #InvisibleIllness #GLP1 #PersonalizedMedicine #PatientAdvocacy #ClinicalTrials #WellnessResearch #ChronicPain #AutoimmuneDisease #PeptideResearch #CallingInSickPodcast #AlexWildeson Learn more about your ad choices. Visit megaphone.fm/adchoices